Kyowa Kirin
Kyowa Kirin is a Japanese pharmaceutical and biotechnology company that creates novel specialty medications for cancer, kidney illness, and immune system diseases. The corporation has a global presence, with subsidiaries in Japan, the United States, the United Kingdom, Singapore, and other European countries, as well as the Middle East and Asia Pacific. Kyowa Kirin's aim is to be a successful Global Specialty Pharmaceutical company based in Japan that creates and delivers life-changing value.
Industries it has a preference for include: Diversified/Conglomerates, Aerospace, Biotechnology, Hardware, Energy & Utilities, Healthcare, Manufacturing, Pharmaceuticals Verticals it has a preference for include: Artificial Intelligence (AI) / Machine Learning, Augmented Reality (AR) / Virtual Reality (VR), Data Services, IoT (Internet of Things), Robotics. It's preferred route(s) to market include: Direct Investments.